Department of Neurosurgery, People's Hospital Affiliated of Ningbo University, East Baizhang Rd 251th, Yinzhou, Zhejiang, 315100, China.
Department of Vascular Surgery, People's Hospital Affiliated of Ningbo University, East Baizhang Rd 251th, Yinzhou, Zhejiang, 315100, China.
Neurosurg Rev. 2024 Sep 3;47(1):524. doi: 10.1007/s10143-024-02760-y.
Magnetic resonance vessel wall imaging (MR-VWI) is an emerging imaging technology used to assess the progressive risk of unruptured intracranial aneurysms (UIAs). Unlike the standard evaluation model, MR-VWI is still debatable. This study aims to further define the potential relationship between aneurysm wall enhancement (AWE) and aneurysm stability. Using "intracranial aneurysm", "magnetic resonance", and "enhancement" as keywords, relevant studies were systematically searched in PubMed, Embase, and Cochrane, and the qualified studies were enrolled for further analysis. There were 13 case-control studies, 4 cohort studies, and 2,678 cases of intracranial aneurysms included in the meta-analysis. It was shown that AWE was correlated with intracranial aneurysm rupture (OR = 35.90, 95% CI: 15.58 to 82.75, p < 0.001), growth (OR = 6.69, 95% CI: 2.69 to 16.63, p < 0.001), and presence of symptoms (OR = 14.46, 95% CI: 9.07 to 23.05, p < 0.001). This finding had a high diagnostic value, but the correlation was probably not independent of aneurysm size. The pooled relative risks of the follow-up studies revealed that the risk of UIA progression was approximately 3.33 times higher with AWE than without AWE (RR = 3.33, 95% CI: 2.33 to 4.78, p < 0.001). In addition, the pooled results demonstrated that quantitative indices of VWI enhancement were equally linked with aneurysm stability (OR = 19.61, 95% CI: 10.63 to 36.17, p < 0.001). AWE is an effective imaging method to assess the stability of UIAs, and it can be a marker for the prophylactic treatment of small unruptured intracranial aneurysms in the future, which remains to be validated by prospective studies with large samples.
磁共振管壁成像(MR-VWI)是一种新兴的成像技术,用于评估未破裂颅内动脉瘤(UIAs)的进展风险。与标准评估模型不同,MR-VWI 仍存在争议。本研究旨在进一步确定动脉瘤壁增强(AWE)与动脉瘤稳定性之间的潜在关系。使用“颅内动脉瘤”、“磁共振”和“增强”作为关键字,在 PubMed、Embase 和 Cochrane 中系统地搜索了相关研究,并纳入了合格的研究进行进一步分析。共纳入了 13 项病例对照研究、4 项队列研究和 2678 例颅内动脉瘤,进行了荟萃分析。结果表明,AWE 与颅内动脉瘤破裂(OR=35.90,95%CI:15.58 至 82.75,p<0.001)、生长(OR=6.69,95%CI:2.69 至 16.63,p<0.001)和症状存在(OR=14.46,95%CI:9.07 至 23.05,p<0.001)相关。这一发现具有较高的诊断价值,但这种相关性可能并不独立于动脉瘤大小。随访研究的汇总相对风险表明,与无 AWE 相比,AWE 存在时 UIA 进展的风险约高 3.33 倍(RR=3.33,95%CI:2.33 至 4.78,p<0.001)。此外,汇总结果表明,VWI 增强的定量指标与动脉瘤稳定性同样相关(OR=19.61,95%CI:10.63 至 36.17,p<0.001)。AWE 是评估 UIAs 稳定性的有效成像方法,它可能成为未来小型未破裂颅内动脉瘤预防性治疗的标志物,这仍有待大样本前瞻性研究验证。